VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide

201337 citationsJournal Articlehybrid Open Access

Authors

The -634CC genotype is significantly associated with a shorter PFS in patients treated with a metronomic CTX schedule.

Good health and well-being

Published in: British Journal of Cancer

Volume 109, Issue 4, pp. 957-964

Field-Weighted Citation Impact: 4.03